Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 776

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 776
---
 |
| Net loss                                                                                        |     | $                                | (1,980,810 | ) |     | $    | (12,172,029 | ) |     | $    | (16,495,680 | ) |
| Defined pension plan adjustments                                                                |     |                                  |    266,924 |   |     |      |    (107,280 | ) |     |      |     100,948 |   |
| Total comprehensive loss                                                                        |     | $                                | (1,713,887 | ) |     | $    | (12,279,309 | ) |     | $    | (16,394,732 | ) |
| Basic and diluted net loss per common share                                                     |     | $                                |      (2.63 | ) |     | $    |      (12.75 | ) |     | $    |      (33.52 | ) |
| Weighted average common shares used in computing basic and diluted net loss per common share    |     |                                  |  1,543,283 |   |     |      |     954,401 |   |     |      |     492,066 |   |

____________ (i) Adjusted for the effect of a 1 -to-40reverse share split that was effective September 27, 2024 (See note 2). The accompanying notes are an integral part of these consolidated financial statements.

Annex F-5

NLS PHARMACEUTICS LTD. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT) FOR THE YEARS ENDED DECEMBER 31, 2024, 2023 AND 2022

| Shares                                                        |     | Preferred Shares | Amount |     |   |          | Shares |     | Common Shares 
        Amount |     |   |           |     | Additional 
 Paid in    
 Capital    |            |   |     | (Accumulated 
 Deficit)     |             |   |     | Accumulated   
 Other         
 Comprehensive 
 Loss          |          |   |     | Total |             |   |
|:--------------------------------------------------------------|:----|-----------------:|:-------|:----|:--|---------:|:-------|:----|--------------:|:----|:--|----------:|:----|:-----------|-----------:|:--|:----|:-------------|:------------|:--|:----|